Industry & Corporation Research Partnerships

MUSC South Carolina Clinical and Translational Research Institute

The South Carolina Clinical and Translational Research (SCTR) Institute is funded largely in-part from a grant by the National Institute of Health’s Clinical and Translational Science Award (CTSA). The CTSA program is the catalyst for changing the culture of biomedical research, facilitating sharing of resources and expertise, and streamlining research-related processes to bring about large-scale change in the clinical and translational research efforts in South Carolina. Our vision is to improve health outcomes and quality of life for the population through discoveries translated into evidence-based practice.

MUSC Foundation for Research Development

MUSC’s affiliated not-for-profit research foundation, the MUSC Foundation for Research Development (FRD) interfaces with industry in the area of technology transfer.  These activities result in a contribution to MUSC’s overall economic impact for our state and nation. Most importantly, by collaborating with industry, cutting-edge discoveries have the opportunity to become real-life solutions to today’s medical problems. FRD’s portfolio of more than 70 technologies available for licensing, including therapeutics, medical devices, software and diagnostics.